Legend Biotech
LEGN
LEGN
204 hedge funds and large institutions have $2.91B invested in Legend Biotech in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 74 increasing their positions, 80 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $3.23B → $2.91B (-$324M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
44% less call options, than puts
Call options by funds: $9.37M | Put options by funds: $16.8M
Holders
204
Holding in Top 10
7
Calls
$9.37M
Puts
$16.8M
Top Buyers
| 1 | +$40.8M | |
| 2 | +$20.7M | |
| 3 | +$20.5M | |
| 4 |
Morgan Stanley
New York
|
+$20.3M |
| 5 |
IAMH
IvyRock Asset Management (HK)
Sheung Wan,
Hong Kong
|
+$19.6M |
Top Sellers
| 1 | -$244M | |
| 2 | -$93.3M | |
| 3 | -$52.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$30.5M |
| 5 |
JPMorgan Chase & Co
New York
|
-$23M |
